Khiron Life Sciences Announces German Cannabis Distribution Deal

Khiron Life Sciences (TSXV: KHRN) has signed a German distribution deal with that of Nimbus Health for its medical cannabis products. Nimbus is a leading distributor of medical cannabis products within Germany.

Under the terms of the arrangement, Khiron will see the first import and sale of its branded EU GMP medical cannabis products within the third quarter of 2020. The product will be available for prescription by doctors, which will then be dispensed by pharmacies within Nimbus’ network.

Medical education and marketing activities for Khiron’s products within the German marketplace are to begin imminently, as a means of building demand prior to the official launch of the first sales within the country. The size of the first shipment to the nation was not disclosed.

“This is a major milestone for our company. Following our recent entry into the United Kingdom, the expansion into Germany will greatly benefit patients who still suffer from inconsistent supply. Khiron is now well positioned to service this rapidly expanding market in Germany.”

Tejinder Virk, President of Khiron Europe

The German medical market is the largest medical cannabis market within Europe. The nation saw €123 million worth of medical cannabis sold in 2019, which was fully reimbursed patient prescriptions. Prohibition Partners currently projects the market to grow to €7.7 billion by 2028.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

Khiron Life Sciences last traded at $0.56 on the TSX Venture.


FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Khiron Passes 1,000 Patient Prescriptions in Colombia, Issues Corporate Update

Khiron Life Sciences (TSXV: KHRN) this morning issued a corporate update, chief among which included...

Monday, July 27, 2020, 09:00:38 AM

The Deep Dive Spotlight Series: Chris Naprawa of Khiron Life Sciences

The Deep Dive is stepping up our programming. We’re upgrading our Canadian small cap coverage...

Saturday, June 6, 2020, 09:00:00 AM

Harvest Moon: Khiron Life Sciences Posts Encouraging Earnings

Overall, we view the recent announcements and earnings surrounding Khiron Life Sciences (TSXV: KHRN) as...

Tuesday, May 5, 2020, 08:50:19 AM

Khiron Life Sciences Announces First Medical Cannabis Clinic In Europe

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the opening of Zerenia Clinics UK in...

Wednesday, November 3, 2021, 11:03:00 AM

Khiron Life Sciences Receives Authorization For The Sale Of High-CBD Medical Cannabis In Peru

Khiron Life Sciences (TSXV: KHRN) announced this morning that it now has access to yet...

Thursday, July 23, 2020, 08:59:43 AM